Immupharma (IMM)

 

Latest News

Annual Report & Notice of AGM

RNS Number: 3430H Immupharma PLC 07 June 2017 7 June 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") ANNUAL REPORT AND ACCOUNTS POSTED TO SHAREHOLDERS NOTICE OF ANNUAL GENERAL MEETING ON 30 JUNE 2017 @ 10.30 AM INVESTOR PRESENTATION TO FOLLOW AT 11.30 AM VENUE: SKY LIGHT CITY...

ImmuPharma losses widen

ImmuPharma's overall losses rose to 5.3m in the year to the end of December - up from 3.9m in 2015. The group said this w...

Final Results

RNS Number: 7561G Immupharma PLC 01 June 2017 1 JUNE 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") FINAL RESULTS ANNOUNCEMENT for the twelve months ended 31 December 2016 ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, is pleased to announce it...

Notification of Full Year Results

RNS Number: 7012F Immupharma PLC 22 May 2017 22 MAY 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") NOTIFICATION OF FULL YEAR RESULTS Date: 1 June 2017 ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, confirms that it will be announcing its full year results for the year ended 31 Decembe...

All News

DateHeadlineSource
07-06-17Annual Report & Notice of AGMRNS
01-06-17ImmuPharma losses widenStockMarketWire
01-06-17Final ResultsRNS
22-05-17Notification of Full Year ResultsRNS
17-05-17Lupuzor study on track, says ImmuPharma StockMarketWire
17-05-17Update on Lupuzor Phase III StudyRNS
31-03-17New Employee Share Option Plan & Grant of OptionsRNS
31-03-17New Employee Share Option Plan & Grant of OptionsRNS
24-03-17ImmuPharma to present at Master Investor ShowRNS
22-03-17Holding(s) in CompanyRNS
20-03-17Holding(s) in CompanyRNS
20-03-17Holding(s) in CompanyRNS
10-03-17?4.1 Million Fund Raise via Accelerated BookbuildRNS
10-03-17Accelerated Bookbuild for the Issue of EquityRNS
06-03-17Holding(s) in CompanyRNS
17-02-17Holding(s) in CompanyRNS
25-01-17Update on Lupuzor Phase III StudyRNS
24-01-17Change of AdviserRNS
29-12-16Holding(s) in CompanyRNS
22-12-16ImmuPharma completes Lupuzor patient recruitment StockMarketWire
22-12-16Update on Lupuzor Pivotal Phase III StudyRNS
16-11-16ImmuPharma update on cancer compound StockMarketWire
16-11-16Update on Cancer Compound IPP-204106 'Nucant'RNS
09-11-16Holding(s) in CompanyRNS
26-10-16Holding(s) in CompanyRNS
24-10-16ImmuPharma fundraising StockMarketWire
21-10-16Close of Accelerated BookbuildRNS
21-10-16ImmuPharma placing StockMarketWire
21-10-16Proposed Accelerated Bookbuild for Vendor PlacingRNS
30-09-16ImmuPharma losses increase StockMarketWire
30-09-16Half-year ReportRNS
14-09-16ImmuPharma update on Lupuzor study StockMarketWire
14-09-16UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDYRNS
07-09-16ImmuPharma to open new site in Lupuzor study StockMarketWire
07-09-16UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDYRNS
21-07-16Holding(s) in CompanyRNS
20-07-16Broker Forecast - Northland Capital issues a broker note on ImmuPharma PLCStockMarketWire
01-07-16Holding(s) in CompanyRNS
27-06-16Second Price Monitoring ExtnRNS
27-06-16Price Monitoring ExtensionRNS

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory